Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Kingworld Medicines Group Ltd
1110Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceutical, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibition; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It serves in the People's Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China. Address: Majialong Chuangxin Building, Shenzhen, China, 518016
Analytics
Objectif de Cours de WallStreet
14.08 HKDRatio C/B
7.75Rendement du dividende
7.31 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 1110
Analyse des dividendes 1110
Croissance des dividendes sur 5 ans
-28 %Croissance continue
2 annéesRatio de distribution Moyenne sur 5 ans
55 %Historique des dividendes 1110
Valorisation des titres 1110
financières 1110
Résultats | 2019 | Dynamique |